Abstract

Marine bioresources are a valuable source of bioactive compounds with industrial and nutraceutical potential. Numerous clinical trials evaluating novel chemotherapeutic agents derived from marine sources have revealed novel mechanisms of action. Recently, marine-derived bioactive peptides have attracted attention owing to their numerous beneficial effects. Moreover, several studies have reported that marine peptides exhibit various anti-infective activities, such as antimicrobial, antifungal, antimalarial, antiprotozoal, anti-tuberculosis, and antiviral activities. In the last several decades, studies of marine plants, animals, and microbes have revealed tremendous number of structurally diverse and bioactive secondary metabolites. However, the treatments available for many infectious diseases caused by bacteria, fungi, and viruses are limited. Thus, the identification of novel antimicrobial peptides should be continued, and all possible strategies should be explored. In this review, we will present the structures and anti-infective activity of peptides isolated from marine sources (sponges, algae, bacteria, fungi and fish) from 2006 to the present.

Highlights

  • Marine organisms are important sources of bioactive molecules that have been used to treat various diseases

  • The ariakemicins were tested against a panel of microbial strains consisting of three gram-positive bacteria (Brevibacterium sp., S. aureus, and B. subtilis: 83 μg/mL), four gram-negative bacteria (Cytophaga marinoflava, Pseudovibrio sp., E. coli, and P. aeruginosa: 83 μg/mL), and a yeast (C. albicans)

  • Pseudodistoma antinboja by activity-guided fractionations [53]. These compounds were evaluated for their antibacterial activity, and most of them exhibited moderate to significant activity that selectively targeted Gram-positive strains (S. aureus, S. epidermidis, Kocuria rhizophila and B. subtilis; MIC = 0.2–12.5 μg/mL)

Read more

Summary

Introduction

Marine organisms are important sources of bioactive molecules that have been used to treat various diseases. Despite tremendous progress in medicine, infectious diseases caused by bacteria, fungi, and viruses are still a major threat to public health. Their impact is large in developing countries due to the lack of access to medicines and the emergence of widespread drug resistance. Marine peptides are specific protein fragments that in addition to acting as sources of nitrogen and amino acids have numerous potential physiological functions [7]. These peptides have been obtained from algae, fish, mollusk, crustacean, crab and marine bacteria and fungus. We will present the structures and anti-infective activity of peptides isolated from the main marine organisms and microorganisms of interest (sponges, algae, bacteria, fungi and fish) from 2006 to the present

Sponges
Microorganism
Antibacterial Activity
Aurelin
Arenicin-1
Tauramamide
Hepcidins
Scygonadin
Tunichromes
Bacillistatins 1 and 2
Thiopeptide TP-1161
Centrocins
3.1.10. Halocyntin and Papillosin
3.1.11. Hyastatin
3.1.12. Indigoidine
3.1.13. Unnarmicins
3.1.14. Ngercheumicins
3.1.15. Solonamides
3.1.16. Cyclo-Peptides
3.1.17. Ariakemicins
3.1.18. Damicornin
3.1.19. Clavanins
3.1.20. Cadiolides
3.1.21. Cytosporones B and E
3.1.22. Anthracimycin
Antifungal Activity
Halocidin
Callipeltins J and K
Pedein A
Theonellamide
Theopapuamides
Surfactin
Anti-CA Cyclic Lipopeptide
Maribasins A and B
Mojavensin A
3.2.10. Kahalalides
3.2.11. Miuraenamides
3.2.12. Callyaerin
Anti-Malarial Activity
Dragomabin
Venturamides
Aerucyclamides
Gallinamide A
Lagunamide A and B
Albopunctatone
Antiprotozoal Activity
Viridamides
Almiramides
Valinomycin
Diketopiperazines
Antituberculosis Activity
Anti-Viral Activity
Mollamide B
Papuamides
Celebesides A and C
Asperterrestide A
Homophymine A
Koshikamide
Conclusions
Findings
Conflicts of Interest
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call